pirinixic acid has been researched along with Atherogenesis in 3 studies
pirinixic acid: structure
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, S | 1 |
| Kanno, Y | 1 |
| Li, W | 1 |
| Sasaki, T | 1 |
| Zhang, X | 1 |
| Wang, J | 1 |
| Cheng, M | 1 |
| Koike, K | 1 |
| Nemoto, K | 1 |
| Li, H | 1 |
| Zahradka, P | 1 |
| Babaev, VR | 1 |
| Ishiguro, H | 1 |
| Ding, L | 1 |
| Yancey, PG | 1 |
| Dove, DE | 1 |
| Kovacs, WJ | 1 |
| Semenkovich, CF | 1 |
| Fazio, S | 1 |
| Linton, MF | 1 |
1 review available for pirinixic acid and Atherogenesis
| Article | Year |
|---|---|
Cardiovascular actions of the peroxisome proliferator-activated receptor-alpha (PPARalpha) agonist Wy14,643.
Topics: Animals; Atherosclerosis; Cardiovascular Diseases; Cardiovascular System; Disease Models, Animal; Hu | 2007 |
2 other studies available for pirinixic acid and Atherogenesis
| Article | Year |
|---|---|
Identification of Picrasidine C as a Subtype-Selective PPARĪ± Agonist.
Topics: Alkaloids; Animals; Atherosclerosis; Carbolines; Cholesterol; Glucose; Hypercholesterolemia; Indoles | 2016 |
Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
Topics: Animals; Aortic Diseases; Atherosclerosis; Biological Transport; Bone Marrow Transplantation; Butyra | 2007 |